Showing results (1381-1390 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|July 1, 2022
Progression of precision statin prescribing for reduction of statin-associated muscle symptomsNatasha J Petry, Jordan F Baye, Samantha Frear, et al.
Pharmacogenomics|May 25, 2019
Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham, Anchalee Avihingsanon, Narukjaporn Thammajaruk, et al.
Pharmacogenomics|May 25, 2019
The GNAS SNP c.393C>T (rs7121) as a marker for disease progression and survival in cancerBirte Möhlendick, Kurt W Schmid, Winfried Siffert
Pharmacogenomics|August 18, 2010
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patientsKim De Ruyck, Kristiaan Nackaerts, Laurence Beels, et al.
Pharmacogenomics|August 18, 2010
IFN-beta pharmacogenomics in multiple sclerosisKoen Vandenbroeck, Elena Urcelay, Manuel Comabella
Pharmacogenomics|August 18, 2010
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practiceAlessio Squassina, Mirko Manchia, Vangelis G Manolopoulos, et al.
Pharmacogenomics|December 3, 2010
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetineKeh-Ming Lin, Hsiao-Hui Tsou, I-Ju Tsai, et al.
Pharmacogenomics|December 3, 2010
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysisMichelle N Sicard, Clement C Zai, Arun K Tiwari, et al.
Pharmacogenomics|December 23, 2010
Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatinMichael A Gordon, Wu Zhang, Dongyun Yang, et al.
Pharmacogenomics|December 23, 2010
How can we identify parasite genes that underlie antimalarial drug resistance?Tim Anderson, Standwell Nkhoma, Andrea Ecker, et al.
Pageof 274